Targeting ROBOs and SLIT guidance cues
in the immune-suppressive stromal context
of pancreatic cancer
Our contribution to the TRanSLIT consortium involves the development of ROBO-SLIT activation signatures from transcriptomic profiles obtained on diverse sampling methods for direct a clinical application.
Partner 3 is a pancreatic cancer research group building on the synergy between anatomopathology (Jérôme Cros) and computational cancer biology (Rémy Nicolle). Our group focuses on the intra-patient heterogeneity of pancreatic adenocarcinoma as well as the intralesion heterogeneity and plasticity, both in neoplastic and preneoplastic tumors.Our contribution to the TRanSLIT consortium involves the development of ROBO-SLIT activation signatures from transcriptomic profiles obtained on diverse sampling methods for direct a clinical application.
Centre de recherche sur l’inflammation
Faculté de médecine site Bichat 16 rue Henri Huchard
F-75018 Paris
France
Ilse Rooman
Laarbeeklaan 103
1090 Brussels
Belgium
Targeting ROBOs and SLIT guidance cues
in the immune-suppressive stromal context
of pancreatic cancer